BRISTOL MYERS SQUIBB CO
BMY · NYSE, NYSE · CIK 0000014272
SIC 2834
Pharmaceutical Preparations
Category
Chemicals
Entity
operating
Incorp.
DE
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$55.67
-0.49 (-0.87%)
Open
$56.18
High
$56.49
Low
$55.41
Prev Close
$56.16
Volume
6,627,727
Quote as of: 2026-05-11
ROE
38.19%
ROA
7.83%
D/E Ratio
3.87
Current Ratio
1.26
Gross Margin
63.79%
Net Margin
14.64%
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-02-11
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 48,194 | 48,300 | 45,006 | 46,159 | 46,385 |
| Cost of Revenue | 13,936 | 13,968 | 10,693 | 10,137 | 9,940 |
| Net Income | 7,054 | -8,948 | 8,025 | 6,327 | 6,994 |
| EPS (Basic) | 3.47 | -4.41 | 3.88 | 2.97 | 3.15 |
| EPS (Diluted) | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 90,038 | 92,603 | 95,159 | 96,820 | 109,314 |
| Current Assets | 29,390 | 29,780 | 31,770 | 27,273 | 33,262 |
| Cash & Equivalents | 10,209 | 10,346 | 11,464 | 9,123 | 13,979 |
| Total Liabilities | 71,533 | 76,215 | 65,674 | 65,702 | 73,308 |
| Current Liabilities | 23,417 | 23,774 | 22,262 | 21,890 | 21,868 |
| Long-term Debt | 44,827 | 49,431 | 39,526 | 38,953 | 44,369 |
| Total Equity | 18,473 | 16,335 | 29,430 | 31,061 | 35,946 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 14,156 | 15,190 | 13,860 | 13,066 | 16,207 |
| Investing CF | -4,132 | -21,352 | -2,295 | -1,062 | -538 |
| Financing CF | -10,348 | 5,127 | -9,416 | -16,962 | -16,224 |
| CapEx | 1,311 | 1,248 | 1,209 | 1,118 | 973 |
| Dividends Paid | 5,045 | 4,863 | 4,744 | 4,634 | 4,396 |
📄 SEC Filings
Current Report
CURRENT REPORT
2026-05-08
Open →
Quarterly Report
10-Q
2026-04-30
Open →
Current Report
8-K
2026-04-30
Open →
Proxy Statement
DEF 14A
2026-03-25
Open →
Annual Report
10-K
2026-02-11
Open →
Current Report
8-K
2026-02-05
Open →
Current Report
CURRENT REPORT
2026-01-12
Open →
Current Report
CURRENT REPORT
2025-11-18
Open →
Current Report
FORM 8-K
2025-11-10
Open →
Current Report
CURRENT REPORT
2025-11-03
Open →
Quarterly Report
10-Q
2025-10-30
Open →
Current Report
8-K
2025-10-30
Open →
Quarterly Report
10-Q
2025-07-31
Open →
Current Report
8-K
2025-07-31
Open →
Current Report
CURRENT REPORT
2025-07-25
Open →
Other filings (85)
S-8
S-8
2026-05-08
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-29
Open →
DEFA14A
DEFA14A
2026-04-17
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
144
xsl144X01/primary_doc.xml
2026-04-01
Open →
15-12G
15-12G
2026-03-27
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-26
Open →
ARS
ARS
2026-03-25
Open →
DEFA14A
DEFA14A
2026-03-25
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2026-01-05
Open →
Insider Transaction
FORM 4
2026-01-05
Open →
Insider Transaction
FORM 4
2026-01-05
Open →
Insider Transaction
FORM 4
2026-01-05
Open →
Insider Transaction
FORM 4
2026-01-05
Open →
CERT
NYSE CERTIFICATION
2025-11-12
Open →
8-A12B
8-A12B
2025-11-10
Open →
424B5
424B5
2025-11-07
Open →
FWP
FWP
2025-11-05
Open →
Insider Transaction
FORM 4
2025-11-04
Open →
Insider Transaction
FORM 4
2025-11-04
Open →
Insider Transaction
FORM 4
2025-11-04
Open →
Insider Transaction
FORM 4
2025-11-04
Open →
424B2
424B2
2025-11-03
Open →
POSASR
POSASR
2025-10-31
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2025-10-31
Open →
Insider Transaction
FORM 4
2025-10-06
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-09-03
Open →
Insider Transaction
FORM 4
2025-09-03
Open →
144
xsl144X01/primary_doc.xml
2025-09-02
Open →
Insider Transaction
FORM 4
2025-08-05
Open →
3
FORM 3
2025-08-05
Open →
Insider Transaction
FORM 4
2025-08-05
Open →
Insider Transaction
FORM 4
2025-08-05
Open →
Insider Transaction
FORM 4
2025-07-02
Open →
Insider Transaction
FORM 4
2025-07-01
Open →
Insider Transaction
FORM 4
2025-07-01
Open →
Insider Transaction
FORM 4
2025-07-01
Open →
Insider Transaction
FORM 4
2025-07-01
Open →
Insider Transaction
FORM 4
2025-07-01
Open →
3
FORM 3
2025-06-16
Open →
Insider Transaction
FORM 4
2025-06-16
Open →
11-K
FORM 11-K
2025-06-06
Open →
11-K
FORM 11-K
2025-06-06
Open →
11-K
FORM 11-K
2025-06-06
Open →
Insider Transaction
FORM 4
2025-06-04
Open →
3
FORM 3
2025-06-04
Open →